Property Market Insights - Perfect Time to Invest in Luxury Property in St. Tropez

Owners of luxury property in the coveted South of France are reducing their prices during the winter months.

2014-02-27

ST. TROPEZ, FRANCE, February 27, 2014 (Press-News.org) Luxury property expert William McIntosh of Carlton International has announced that owners of luxury properties have reduced their prices by up to 250,000EUR until mid April.

McIntosh explains that the price drops indicate a very normal trend in the market on the French Riviera where luxury properties tend to sell better when the sun shines. It's a fantastic time to buy property in some of the most exclusive postcodes in the South of France before the spring-summer rush when there is more competition and prices naturally rise.

Speaking of the trend McIntosh stated that "genuinely good deals do get snapped up and in the winter there are fewer competing buyers around to 'bid up' the price."

Because property sales are slower in the winter, the people involved in the transaction such as notaires, tax experts and lenders are far easier to reach and have more time available so real estate purchases go much more smoothly and quicker than in the summer months.

Following a drop in South of France real estate prices in 2013 some property owners found their luxury homes stayed on the market. Having missed the opportunity to sell in high season they are far more willing to negotiate on price.

McIntosh added that "prices are at, or very close to, the bottom, so the timing to buy now is perfect. I feel that prices will start increasing, or at the least level off, this summer. St. Tropez is a very small micro market so prices do not drop here as much as other areas on the Cote d'Azur."

William McIntosh, who has been selling luxury homes since 1982, has arranged special winter sale prices with a few select clients and offers two amazing properties with very large winter discounts.

For example, a gorgeous brand new contemporary style villa in St. Tropez with panoramic sea views, olive trees and even a small vineyard, is on sale. The asking price of 5,850,000 has dropped to 5,600,000 until April 15, a saving of 250,000 euros.

Another modern style villa for sale in in St. Tropez is available for 3,600,000 euros, 200,000 less than the usual asking price of 3,800,000 euros. The villa enjoys panoramic sea views and has been fully renovated.

If you are planning on buying property in the St. Tropez area, you can contact William McIntosh about these or any of his other properties at william@carlton-international.com or visit the website at www.carlton-international.com.

ABOUT CARLTON INTERNATIONAL

Carlton International is a prestigious real-estate agency based in the South of France. Our experienced consultants consistently negotiate French property transactions at the highest end of the market earning us a reputation as specialists in luxury French Riviera property sales and rentals. We offer a discreet service allowing our wealthy customers the privacy required for such transactions.

For those looking to purchase luxury property on the French Riviera, Carlton International can assist you in your search. Carlton International represents some of the most exclusive property for sale in the south of France. St. Tropez, Cap D'Antibes, Cap Ferrat and Cannes real estate are all available to be viewed through the website at www.carlton-international.com.

[Attachments] See images for this press release:

ELSE PRESS RELEASES FROM THIS DATE:

CNIO researchers discover new strategies for the treatment of psoriasis

2014-02-27

Almost ten years ago, the group led by Erwin Wagner, currently at the Spanish National Cancer Research Centre (CNIO), developed genetically modified mice showing symptoms very reminiscent to psoriasis. After publishing this discovery in Nature, the researchers decided to use this mouse model to study the underlying molecular pathways involved in disease development, and to look for innovative and efficient therapies. Now the group has discovered two possible novel treatments, based on existing pharmacological compounds, which are likely to cause fewer side effects. Psoriasis ...

Scientists discover new protein involved in lung cancer

2014-02-27

Scientists from The University of Manchester – part of the Manchester Cancer Research Centre (MCRC) - have discovered a new protein that is involved in cancer and inflammation in lung tissue. The findings, published in the Journal of Biological Chemistry, could help in the development of new drugs to target lung cancer. Lung cancer is the most common cause of cancer death in Greater Manchester, with around 930 men and 790 women dying from the disease every year in the area. While there have been major advances in treatments and outcomes for some cancers over the ...

Effective treatment for youth anxiety disorders has lasting benefit

2014-02-27

Washington D.C., February 27, 2013 – A study published in the March 2014 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that the majority of youth with moderate to severe anxiety disorders responded well to acute treatment with cognitive behavioral therapy (CBT), medication (sertraline), or a combination of both. They maintained positive treatment response over a 6 month follow-up period with the help of monthly booster sessions. As part of the NIMH Child/Adolescent Anxiety Multimodal Study (CAMS), a group of researchers led by Dr. ...

New invasive species breakthrough sparks interest around the world

2014-02-27

A research breakthrough at Queen's University Belfast has sparked interest among aquatic biologists, zoologists and ecologists around the world. The joint research between Queen's and several South African institutions centred on the behaviour of some of the "world's worst" invasive species, including the large-mouth bass, an invasive fish which typically devastates invertebrate and other fish communities wherever it is introduced. Previously, the search for general characteristics of invasive species had been elusive, but work carried out by Professor Jaimie Dick ...

More dangerous chemicals in everyday life: Now experts warn against nanosilver

2014-02-27

Endocrine disrupters are not the only worrying chemicals that ordinary consumers are exposed to in everyday life. Also nanoparticles of silver, found in e.g. dietary supplements, cosmetics and food packaging, now worry scientists. A new study from the University of Southern Denmark shows that nano-silver can penetrate our cells and cause damage. Silver has an antibacterial effect and therefore the food and cosmetic industry often coat their products with silver nanoparticles. Nano-silver can be found in e.g. drinking bottles, cosmetics, band aids, toothbrushes, running ...

Probing the edge of chaos

2014-02-27

The edge of chaos—right before chaos sets in—is a unique place. It is found in many dynamical systems that cross the boundary between a well-behaved dynamics and a chaotic one. Now, physicists have shown that the distribution—or frequency of occurrence—of the variables constituting the physical characteristics of such systems at the edge of chaos has a very different shape than previously reported distributions. The results, by Miguel Angel Fuentes from the Santa Fe Institute in New Mexico, USA, and Universidad del Desarrollo, Chile, and Alberto Robledo from the National ...

A novel treatment may reduce myocardial infarction size

2014-02-27

Researchers at the University of Eastern Finland (UEF) have developed a novel treatment for myocardial infarction. In a study carried out at the UEF, virus vectors were used in a mouse model to deliver small RNA molecules into the heart, and this significantly reduced the size of myocardial infarction. In the novel treatment method, RNA molecules are targeted at the regulatory area of the vascular endothelial growth factor gene (VEGF-A). These molecules use epigenetic mechanisms to enhance the production of the growth factor in cells. The study also focused on the mechanisms ...

Over-80s often over-treated for stroke prevention

2014-02-27

People in their 80s are often prescribed drugs to ward off a stroke when the risk of a stroke is not that high and the drugs have other side effects, finds a perspective published online in Evidence Based Medicine. People in this age group are being "over-treated," and doctors need to actively rethink their priorities and beliefs about stroke prevention, argues Dr Kit Byatt of the Department of Geriatric Medicine, The County Hospital in Hereford, UK. Statins and antihypertensive drugs were the most commonly prescribed cardiovascular drugs in the UK in 2006. And they ...

Cesarean babies are more likely to become overweight as adults

2014-02-27

Babies born by caesarean section are more likely to be overweight or obese as adults, according to a new analysis. The odds of being overweight or obese are 26 per cent higher for adults born by caesarean section than those born by vaginal delivery, the study found (see footnote). The finding, reported in the journal PLOS ONE, is based on combined data from 15 studies with over 38,000 participants. The researchers, from Imperial College London, say there are good reasons why many women should have a C-section, but mothers choosing a caesarean should be aware that ...

A road map -- and dictionary -- for the arthropod brain

2014-02-27

When you're talking about something as complex as the brain, the task isn't any easier if the vocabulary being used is just as complex. An international collaboration of neuroscientists has not only tripled the number of identified brain structures, but created a simple lexicon to talk about them, which will be enormously helpful for future research on brain function and disease. Nick Strausfeld and Linda Restifo, both professors in the Department of Neuroscience at the University of Arizona, worked with colleagues in Japan who led the project, and colleagues in Germany ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC